Evotec SE (EVO) Capital Expenditures (2009 - 2026)
Evotec SE's (EVO) quarterly Capital Expenditures came in at -$4.9 million in Q1 2026, up 74.54% year-over-year from -$2.8 million in Q1 2025, and up 88.88% quarter-over-quarter from -$43.8 million in Q4 2025.
Analysis
Evotec SE (EVO) Capital Expenditures (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Capital Expenditures across 9 years of filings, most recently posting -$4.9 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 74.54% year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$94.3 million (up 8.22% YoY), while the FY2025 annual figure was -$82.0 million, up 35.54% from the prior year.
- Capital Expenditures came in at -$4.9 million for Q1 2026 at Evotec SE, up from -$43.8 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $82.2 million in Q3 2022 to a low of -$229.4 million in Q4 2023.
- Average Capital Expenditures over 5 years is -$48.5 million, with a median of -$33.7 million recorded in 2024.
- Year-over-year, Capital Expenditures sank 109924.74% in 2022 and soared 196.05% in 2023.
- Over 5 years, Capital Expenditures stood at -$185.2 million in 2022, then retreated by 23.85% to -$229.4 million in 2023, then surged by 92.92% to -$16.2 million in 2024, then sank by 169.69% to -$43.8 million in 2025, then surged by 88.88% to -$4.9 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$4.9 million in Q1 2026, -$43.8 million in Q4 2025, and -$23.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 198.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 23.91 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -42.42 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 31.11 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 9.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 2.62 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 125,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -4.87 Mn |
| Dec 31, 2025 | -43.81 Mn |
| Sep 30, 2025 | -23.63 Mn |
| Jun 30, 2025 | -22.00 Mn |
| Mar 31, 2025 | -19.14 Mn |
| Dec 31, 2024 | -16.24 Mn |
| Sep 30, 2024 | -29.41 Mn |
| Jun 30, 2024 | -37.96 Mn |
| Mar 31, 2024 | -43.71 Mn |
| Dec 31, 2023 | -229.36 Mn |
| Jun 30, 2023 | -160.23 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Dec 31, 2022 | -185.19 Mn |
| Sep 30, 2022 | 82.20 Mn |
| Jun 30, 2022 | -41.03 Mn |
| Mar 31, 2022 | -48.17 Mn |
| Dec 31, 2021 | -250.67 Mn |
| Sep 30, 2021 | 32.56 Mn |
| Jun 30, 2021 | 87.44 Mn |
| Mar 31, 2021 | -43,782.75 |